Site Selection for Life Sciences Companies: Cluster Report 2013

Site Selection for Life Sciences Companies: Clust...

Access to new technologies, products, talent and markets is critical for Life Sciences (LS) companies' efforts to maintain competiveness and generate growth in an environment characterized by price pressures, fast technological changes and increasingly sophisticated consumers.

1000

Related content

Site Selection for Life Sciences Companies: Cluster Report 2013

Europe is especially interesting for Life Sciences companies from emerging economies and the US seeking to leverage these potential advantages. With its technological leadership and manufacturing know-how, Europe offers interesting opportunities for the acquisition or development of intellectual property (IP ) as well as the production of sophisticated products.

© 2017 KPMG International Cooperative (“KPMG International”), a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. All rights reserved.

Connect with us

KPMG's new digital platform

KPMG International has created a state of the art digital platform that enhances your experience, optimized to discover new and related content.